Audrey P. Rico

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Fatal cerebral toxoplasmosis in a patient with multiple sclerosis treated with natalizumab.

Fatal cerebral toxoplasmosis in a patient with multiple sclerosis treated with natalizumab.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 18, 2026

Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS.

Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS.

Journal: Annals of clinical and translational neurology

Published: December 18, 2025

Long-interval dosing of anti-CD20 therapy: Toward affordable treatment for multiple sclerosis.

Long-interval dosing of anti-CD20 therapy: Toward affordable treatment for multiple sclerosis.

Journal: Revue neurologique

Published: November 18, 2025

Motor tract lesion mapping from the brain to the lower spinal cord in people with relapsing-remitting multiple sclerosis: exploring the association between lesion severity and functional consequences by limb.

Motor tract lesion mapping from the brain to the lower spinal cord in people with relapsing-remitting multiple sclerosis: exploring the association between lesion severity and functional consequences by limb.

Journal: Brain communications

Published: August 29, 2025

Early structural hub disruption leads to premature functional adaption in multiple sclerosis.

Early structural hub disruption leads to premature functional adaption in multiple sclerosis.

Journal: Brain structure & function

Published: July 02, 2025

Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis.

Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: June 19, 2025

Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis.

Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: March 14, 2025

Fluorescein Angiography as a Surrogate Marker of Disease Activity in Susac Syndrome.

Fluorescein Angiography as a Surrogate Marker of Disease Activity in Susac Syndrome.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 05, 2025

Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis.

Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: October 15, 2024

Cortical Lesions as an Early Hallmark of Multiple Sclerosis: Visualization by 7 T MRI.

Cortical Lesions as an Early Hallmark of Multiple Sclerosis: Visualization by 7 T MRI.

Journal: Investigative radiology

Published: June 18, 2024

Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis.

Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 16, 2024

Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis.

Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis.

Journal: Neurology

Published: March 25, 2024

Showing 1-12 of 50

Last Updated: 09/26/2026